InvestorsHub Logo
Followers 403
Posts 58365
Boards Moderated 16
Alias Born 05/01/2010

Re: None

Thursday, 10/20/2022 2:35:28 PM

Thursday, October 20, 2022 2:35:28 PM

Post# of 132363
SPRV
Supurva Healthcare Group,
Inc 5112 West Taft Rd., Suite M
Liverpool, NY 13088

Supplemental Information Disclosure for Supurva Healthcare Group, Inc. (the “Company”):

The Company has entered into a $50,000.00 10% convertible promissory note agreement with an unrelated third party (the “Note”). The Note matures August 24, 2023 and is convertible into the Company’s common stock at a price equal to 55% of the average closing price of the Company’s common stock during the 20 consecutive Trading Days prior to the date on which Holder elects to convert all or part of the Note.

AND

The Company has entered into a $50,000.00 10% convertible promissory note agreement with a related party (the “Note”). The Note matures October 5, 2023 and is convertible into the Company’s common stock at a price equal to 55% of the average closing price of the Company’s common stock during the 20 consecutive Trading Days prior to the date on which Holder elects to convert all or part of the Note.